This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Group (ENSG) Buys Nursing Units, Boosts U.S. Footprint
by Zacks Equity Research
Ensign Group (ENSG) acquires two skilled nursing facilities in Colorado and one similar facility in Kansas to better serve the regions' patients and grow its healthcare portfolio.
HCA Healthcare (HCA) Rises 24.8% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services and Tenet Healthcare have been highlighted in this Industry Outlook article.
Why the Market Dipped But HCA Healthcare (HCA) Gained Today
by Zacks Equity Research
The latest trading day saw HCA Healthcare (HCA) settling at $314.08, representing a +0.67% change from its previous close.
3 Stocks Worth a Deeper Dive in the Thriving Hospital Industry
by Kaibalya Pravo Dey
Following a careful analysis of the Zacks Medical-Hospital industry, we advise focusing on companies like HCA, UHS and THC.
Tenet Healthcare (THC) to Sell Hospitals to Refine Portfolio
by Zacks Equity Research
Tenet Healthcare (THC) enters an agreement with Adventist Health to divest two of THC's hospitals, and continue to make Conifer's revenue cycle management services available for the divested operations.
Can This U.S. "AI" Boom Override Geopolitics?
by John Blank
An Aggressive Posture on Asset Allocation Can Remain Attractive.
Why Is HCA (HCA) Up 2.4% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Buy HCA Healthcare (HCA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HCA Healthcare (HCA) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) reachead $313.20 at the closing of the latest trading day, reflecting a -0.68% change compared to its last close.
Is It Worth Investing in HCA (HCA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HCA Healthcare (HCA) Drives Efficiency With New Outpatient Model
by Zacks Equity Research
HCA Healthcare's (HCA) Sarah Cannon Cancer Institute adopts a new outpatient model for CAR T-cell therapy patients.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HCA Healthcare, Inc. (HCA) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to HCA (HCA). This makes it worthwhile to examine what the stock has in store.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Here's How Much You'd Have If You Invested $1000 in HCA Healthcare a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks Investment Ideas feature highlights: HCA Healthcare, DaVita and General Motors
by Zacks Equity Research
HCA Healthcare, DaVita and General Motors have been highlighted in this Investment Ideas article.
Markets Appear Vulnerable: Hideout in these 3 Top Ranked Defensive Stocks
by Ethan Feller
There are a number of bearish catalysts brewing... is it time to rotate into these defensive names?
Nvidia Reports on the A.I. Boom: Global Week Ahead
by John Blank
After Nvidia's stock more than tripled in 2023, the chipmaker at the center of the excitement over A.I. has seen its shares soar another roughly +50% so far this year.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
5 Must-Buy Growth Stocks for Sparkling Returns in Near Future
by Nalak Das
We have narrowed our search to five growth stocks that have solid upside left for 2024. These are: AMZN, RCL, PGR, HCA, APP.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Elevance Health (ELV) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
5 High ROE Stocks to Bet on as Markets Sway Whimsically
by Supriyo Bose
Arch Capital (ACGL), Suzano (SUZ), Carlisle (CSL), HCA Healthcare (HCA) and America Movil (AMX) are some of the stocks with high ROE to profit from as markets swing wildly.